ORMOSIL nanoparticles as a non-viral gene delivery vector for modeling polyglutamine induced brain pathology

Journal of Neuroscience Methods

Volumn 165, Issue 2, 2007, Pages 230-243

  Klejbor, I ^a,b,c   Stachowiak, E K ^a,b   Bharali, D J ^a   Roy, I ^a   Spodnik, I ^c   Morys, J ^c   Bergey, E J ^a   Prasad, P N ^a   Stachowiak, M K ^a,b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Animal models; Gene transfer; Huntington disease; Nanoparticles; Poly glutamine disorders

Indexed keywords

GLUTAMINE; HEMAGGLUTININ; NANOPARTICLE; ORGANICALLY MODIFIED SILICA; POLYGLUTAMINE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CORTEX; BRAIN DISEASE; BRAIN LATERAL VENTRICLE; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATIVE DISEASE; FEMALE; GENE TRANSFER; HUNTINGTON CHOREA; IMMUNOCYTOCHEMISTRY; MALE; MOTOR DYSFUNCTION; MOUSE; NANOTECHNOLOGY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; RAT; SEPTUM PELLUCIDUM;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DNA REPEAT EXPANSION; ECTODYSPLASINS; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLIOSIS; HUNTINGTON DISEASE; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, TRANSGENIC; NANOPARTICLES; NERVE DEGENERATION; PEPTIDES; PLASMIDS; RATS; RATS, WISTAR; SILICON DIOXIDE; SILOXANES; TRANSFECTION;

EID: 34547751843     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneumeth.2007.06.011     Document Type: Article

References (35)

1. Anderson W.F. Human gene therapy. Nature 392 6679 (1998) 25-30
2. Bates G.P., Mangiarini L., Mahal A., and Davies S.W. Transgenic models of Huntington's disease. Hum Mol Genet 6 10 (1997) 1633-1637
3. Bharali D.J., Klejbor I., Stachowiak E.K., Dutta P., Roy I., Kaur N., et al. Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci USA 102 32 (2005) 11539-11544
4. Corso TD, Toress G, Roy I, Gambino AS, Nayda J, Buckley T, Stachowiak EK, Bergey EJ, Pudavar H, Dutta P, Bloom D, Bowers WJ, Stachowiak MK. in press.Viral and non-viral gene transfer into adult rat brain.
5. Corso T.D., Torres G., Goulah C., Roy I., Gambino A.S., Nayda J., et al. Assessment of viral and non-viral gene transfer into adult rat brains using HSV-1, calcium phosphate and PEI-based methods. Folia Morphol (Warsz) 64 3 (2005) 130-144
6. Corso T.D., Torres G., Goulah C., Roy I., Gambino A.S., Nayda J., et al. Transfection of tyrosine kinase deleted FGF receptor-1 into rat brain substantia nigra reduces the number of tyrosine hydroxylase expressing neurons and decreases concentration levels of striatal dopamine. Brain Res Mol Brain Res 139 2 (2005) 361-366
7. Curtis M.A., Penney E.B., Pearson J., Dragunow M., Connor B., and Faull R.L. The distribution of progenitor cells in the subependymal layer of the lateral ventricle in the normal and Huntington's disease human brain. Neuroscience 132 3 (2005) 777-788
8. Davis S.S. Biomedical applications of nanotechnology-implications for drug targeting and gene therapy. Trends Biotechnol 15 6 (1997) 217-224
9. Eclancher F., Kehrli P., Labourdette G., and Sensenbrenner M. Basic fibroblast growth factor (bFGF) injection activates the glial reaction in the injured adult rat brain. Brain Res 737 1-2 (1996) 201-214
10. Fang X., Stachowiak E.K., Dunham-Ems S.M., Klejbor I., and Stachowiak M.K. Control of CREB-binding protein signaling by nuclear fibroblast growth factor receptor-1: a novel mechanism of gene regulation. J Biol Chem 280 31 (2005) 28451-28462
11. Fayazi Z., Ghosh S., Marion S., Bao X., Shero M., and Kazemi-Esfarjani P. A Drosophila ortholog of the human MRJ modulates polyglutamine toxicity and aggregation. Neurobiol Dis (2006)
12. Heck S., Qian X., and Velleca M. Genetically engineered mouse models for drug discovery: new chemical genetic approaches. Curr Drug Discov Technol 1 1 (2004) 13-26
13. Jantzie L.L., Cheung P.Y., and Todd K.G. Doxycycline reduces cleaved caspase-3 and microglial activation in an animal model of neonatal hypoxia-ischemia. J Cereb Blood Flow Metab 25 3 (2005) 314-324
14. Landles C., and Bates G.P. Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series. EMBO Rep 5 10 (2004) 958-963
15. Lin C.H., Tallaksen-Greene S., Chien W.M., Cearley J.A., Jackson W.S., Crouse A.B., et al. Neurological abnormalities in a knock-in mouse model of Huntington's disease. Hum Mol Genet 10 2 (2001) 137-144
16. Liu B., and Hong J.S. Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304 1 (2003) 1-7
17. Luo D., and Saltzman W.M. Synthetic DNA delivery systems. Nat Biotechnol 18 1 (2000) 33-37
18. Mangiarini L., Sathasivam K., Mahal A., Mott R., Seller M., and Bates G.P. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nat Genet 15 2 (1997) 197-200
19. Mangiarini L., Sathasivam K., Seller M., Cozens B., Harper A., Hetherington C., et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87 3 (1996) 493-506
20. McGeer P.L., and McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21 2 (1995) 195-218
21. McKerlie C. Cause and effect considerations in diagnostic pathology and pathology phenotyping of genetically engineered mice (GEM). Ilar J 47 2 (2006) 156-162
22. Myers R.H., Vonsattel J.P., Paskevich P.A., Kiely D.K., Stevens T.J., Cupples L.A., et al. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus. J Neuropathol Exp Neurol 50 6 (1991) 729-742
23. Myers R.H., Vonsattel J.P., Stevens T.J., Cupples L.A., Richardson E.P., Martin J.B., et al. Clinical and neuropathologic assessment of severity in Huntington's disease. Neurology 38 3 (1988) 341-347
24. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates. 4th ed. (1998), Academic Press
25. Postert T., Lack B., Kuhn W., Jergas M., Andrich J., Braun B., et al. Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography. J Neurol Neurosurg Psychiatry 67 4 (1999) 457-462
26. Prasad P.N. Introduction to biophotonics (2003), John Wiley and Sons, Inc., Hoboken, NJ
27. Prasad P.N. Nanophotonics (2004), John Wiley and Sons, Inc, Hoboken, NJ
28. Reddy P.H., Charles V., Williams M., Miller G., Whetsell Jr. W.O., and Tagle D.A. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease. Philos Trans R Soc Lond B Biol Sci 354 1386 (1999) 1035-1045
29. Ross C.A., and Poirier M.A. Protein aggregation and neurodegenerative disease. Nat Med 10 Suppl (2004) S10-S17
30. Roy I., Ohulchanskyy T.Y., Bharali D.J., Pudavar H.E., Mistretta R.A., Kaur N., et al. Optical tracking of organically modified silica nanoparticles as DNA carriers: a nonviral, nanomedicine approach for gene delivery. Proc Natl Acad Sci USA 102 2 (2005) 279-284
31. Sathasivam K., Hobbs C., Turmaine M., Mangiarini L., Mahal A., Bertaux F., et al. Formation of polyglutamine inclusions in non-CNS tissue. Hum Mol Genet 8 5 (1999) 813-822
32. Schneider J.S., and Denaro F.J. Astrocytic responses to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in cat and mouse brain. J Neuropathol Exp Neurol 47 4 (1988) 452-458
33. Tabbaa S., Goulah W.M., Tran R.K., Lis A., Korody R., Stachowski B., et al. Gene transfer into the central nervous system using herpes simplex virus-1 vectors. Folia Morphologica (Warszawa) 59 4 (2000) 221-232
34. Turmaine M., Raza A., Mahal A., Mangiarini L., Bates G.P., and Davies S.W. Nonapoptotic neurodegeneration in a transgenic mouse model of Huntington's disease. Proc Natl Acad Sci USA 97 14 (2000) 8093-8097
35. Vis J.C., Nicholson L.F., Faull R.L., Evans W.H., Severs N.J., and Green C.R. Connexin expression in Huntington's diseased human brain. Cell Biol Int 22 11-12 (1998) 837-847